World / 18 kids deaths in Uzbekistan due to cough syrup made in Noida mansukh mandaviya said probe on

New Delhi : After accusing Gambia of India's Medan Pharma Company's cough syrup, now the Government of Uzbekistan has made a big allegation against an Indian Pharma company. On Tuesday, Uzbekistan's Ministry of Health issued a statement saying that 18 children in their country have lost their lives after drinking cough syrup from Noida-based pharma company Marion Biotech Private Limited. The Central Drugs Standard Control Organization (CDSCO) has started an investigation against an Indian company in connection with the death of 18 children in Uzbekistan.

However, this company is registered in Uzbekistan since 2012. On Tuesday, the Ministry of Health has told that 18 children lost their lives after drinking cough syrup Doc-1 Max Syrup, which came from Noida's pharma company. Two months ago, Gambia also alleged that 66 children in their country lost their lives due to cough syrup of Haryana-based pharma company Medan Pharma.

Samples sent for testing

Union Minister of State for Health and Family Welfare Mansukh Mandaviya said, soon after receiving the information, the team of UP Drug Control and CDSCO conducted a joint inspection of the Noida facility of Marion Biotech. Further action will be taken on the basis of the report. Samples of cough syrup taken from the manufacturing premises have been sent to the Regional Drugs Testing Laboratory, Chandigarh for testing.

According to the Ministry of Health of Uzbekistan, 18 out of 21 children died due to drinking Doc-1 Max Syrup. However, all the children were given this medicine without a doctor's prescription. This medicine also contains paracetamol but parents of many children gave it to their children for cough and cold because they got such advice from the chemist.

According to the ministry...

- 18 out of 21 children have died due to taking Doctor-1 Max Syrup.

- It was found that the dead children took this medicine at home, 2.5-5ml, 3-4 times a day for 2-7 days before hospitalization, which is more than the standard dose of medicine for children.

According to the Uzbek government, according to the initial lab reports, ethylene glycol has been found in this syrup. This is the same ingredient that was also found in the cough syrup used in The Gambia.

A panel set up to investigate child deaths in Gambia recently told the government there that the cough syrup was substandard and that an Indian pharma company was to blame. However, through the Drug Controller of India, India had cleared its stand in the WHO and said that the reason for the death of the children was E-Coli bacteria and not cough syrup.